The Computer Scientist's Guide to Designing mRNA Vaccines

Part 2: Antigen Selection Pipeline

2.1. Overview

In this section, we’ll develop a pipeline to identify antigen candidates for an mRNA vaccine against Acinetobacter baumannii, a Gram-negative bacterium that thrives in a variety of environmental conditions. It is commonly found in hospital environments and causes infections such as meningitis, wound infections, and pneumonia. A. baumannii can spread through respiratory-care gear, wound-care instruments, humidifiers, surgical instruments, door knobs, and even mop heads. The bacteria usually target immunocompromised individuals, elevating morbidity and mortality rates by 26.5-91%. Broad-spectrum antibiotics are the most common form of treatment. Yet, the threat posed by the bacteria has grown significantly over the past 15 years, as they have shown increasing resistance to most antibiotics. Currently, there are no vaccines against A. baumannii in phase I-III/clinical trials, which has been designated as a critical pathogen by WHO.

With that said, it’s time to start the most hands-on section of this guide. To make it easier to understand, we’ll do it along the way, with a final subsection dedicated to the overall picture.